Inserts at right lower corner, original magnification 400. == Figure 2 . the MM diagnosis in 12/34 (35. 3%) from the pleural tumors, in 38/56 (67. 9%) of the peritoneal tumors, and in 2/2 (100%) of the MM of the tunica vaginalis. MM were characterized by tumor cells showing nuclear WT1 and calretinin staining and by strong membranous staining for cytokeratin (CK) CAM5. 2 . The epithelial markers, CEA, TTF1, MOC31, BerEP4, p63, p40, PAX8, ER and Rabbit Polyclonal to TAS2R49 PR were unfavorable. BAP1 nuclear staining was lost in percentages similar to what reported for samples from Western countries. == Conclusions == Our findings suggest that MM especially in its pleural localization is often misdiagnosed in Eastern China. Identifying pitfalls and possible solutions in the pathological diagnosis of MM will impact both standard of treatment and research in China. Keywords: mesothelioma, IHC, China, BAP1 == INTRODUCTION == Malignant mesothelioma (MM) is an Ribocil B intense cancer with dismal prognosis and limited therapeutic options, usually associated to exposure to asbestos and other carcinogenic mineral fibers. 1Because of this strong association with asbestos, in Western countries MM is most often diagnosed in the parietal pleura of older males professionally exposed to asbestos. 1 There are very few reports in the English literature about MM in China. 24The MM incidence in China continues to be estimated at 1 . 5 cases/million, 5much lower than in other countries. In addition to the English literature, we reviewed 68 papers representing all of the scientific manuscripts on MM in China that were published in the Chinese literature (Supplementary Table 1). These papers reported a total of 1959 MM diagnoses, 293 associated with asbestos exposure (~15%), compared to over 70% in most of the world. 1This low incidence of asbestos-related MM was unexpected because the use of asbestos in China has not been restricted until recently. Amphibole asbestos was banned in 2002; however , the use of chrysotile asbestos continues, a few, 6although it was banned in selected products: as auto brakes (1999), household appliances (2005), ship-building (2007), and mural material (2010). Asbestos mining and asbestos factories are Ribocil B still present in specific provinces and municipalities in China, such Ribocil B as the province of Zhejiang, Eastern China. We recently discovered that Chinese MMs are surprisingly more common in young women, in the peritoneal localization, and we confirmed that many of these women were not exposed to asbestos. 7These findings are puzzling and their reliability is largely linked to a correct diagnosis. Pathological diagnosis of MM is aid by immunohistochemistry (IHC) and it requires a correct interpretation of the results. We reviewed all the pleural and peritoneal malignancies that were diagnosed as MM during the years 20022015 in two medical centers in the Zheijiang province one that sees prevalently non-asbestos exposed patients, and the other that sees prevalently asbestos Ribocil B exposed patients (see below). == MATERIALS AND METHODS == == Specimen collection == We collected tissue slides used to diagnose 92 putative MMs in the Zhejiang Cancer Center Hospital (ZJCC), the largest university cancer hospital in the province of Zheijiang located in the city of Hangzhou, and in the Yuyao Peoples Hospital (YPH) located 112 km away from Hangzhou, in the town of Yuyao where there is a florid asbestos textile industry. There were a total of 92 diagnoses of MM: 34 in the pleura, 56 in the peritoneum, 2 in the tunica vaginalis. Among confirmed MM 28 were from ZJCC and 24 from Yuyao People Hospital. Demographic and epidemiological information on this set of samples continues to be presented elsewhere. 7This retrospective study was approved by the Zhejiang Cancer Hospital Ethical Committee and the Zhejiang Academy of Medical Sciences Ethical Committee. == Pathological Review == All initial diagnoses of MM were supported by some, at times limited, immunohistochemistry (IHC). The histopathological review of these MMs and of the available IHC- was conducted together by pathologists from the ZJCC (Z. G. ) and from the University of Hawaii Cancer Center (M. C. ) with extensive experience in MM diagnosis. These specimens included tissue biopsies and fine needle biopsies. A set of IHC was ordered based on the histological appearance, sex, and location from the tumor (for example ER and PR stains were ordered only for.